H40
Conditions
Interventions
Group 1: The study prospectively examines the impact of glaucoma surgical procedures on patients' health-related quality of life and subjective symptoms using validated Patient Reported Outcome Measur
Sponsors
Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who are scheduled for a glaucoma surgical procedure (Istent Inject®, trabeculotomy using Trabectome or Kahook dual blade, 360° trabeculotomy following canaloplasty, ab interno canaloplasty, XEN implantation, trabeculectomy, and Ahmed valve or Paul implant), who are capable of giving consent and, after being informed, are willing to participate in the study.
Exclusion criteria
Exclusion criteria: - Persons under 18 years of age. - Persons who are mentally unable to complete the questionnaires for collecting the PROMs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the total score of the GAL-9 (Glaucoma Activity Limitation-9) questionnaire between month 12 and the preoperative measurement time point. | — |
Secondary
| Measure | Time frame |
|---|---|
| • PROMIS 29+4 • GSS (Glaucoma Symptom Scale) • NEI-VFQ-25 (National Eye Institute Visual Functioning Questionnaire) • SFQ (Surgical Fear Questionnaire) • SSQ-8 (Surgical Satisfaction Questionnaire) • Availability of data (yes/no) • Digital participation (yes/no) Demographic and clinical data: • Age and gender • Ethnic background • Severity of glaucoma • Surgeries performed • Information about the condition • Ophthalmological findings (e.g., intraocular pressure) and medications | — |
Countries
Germany
Contacts
Public ContactAnna-Karina Maier-Wenzel
Charité - Universitätsmedizin Berlin
Outcome results
None listed